Displaying 109 to 120 of 132 results

  • Economic Evaluation of Selective Neonatal Bacillus Calmette-Guérin Vaccination of High-risk Infants in Ireland

    Published
    01 Aug 2018
    Read more

  • Contribution of stakeholder engagement to the impact of a health technology assessment: an Irish case study

    Published
    16 Oct 2017
    Read more

  • Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiolog

    Published
    05 Jul 2017
    Read more

  • Clinical-effectiveness of self-management interventions in chronic obstructive pulmonary disease: An overview of reviews

    Published
    24 Feb 2017
    Read more

  • The HIQA's Health Technology Assessment of Breast Screening: Highlighting Some of the Challenges Posed by Evaluations of Screening Programs

    Published
    13 Jan 2017
    Read more

  • Economic evaluation of chronic disease self-management for people with diabetes: a systematic reviewv

    Published
    22 Oct 2016
    Read more

  • Cost-Effectiveness of a National Opportunistic Screening Program for Atrial Fibrillation in Ireland

    Published
    05 Oct 2016
    Read more

  • Systematic screening for the detection of atrial fibrillation: Update

    Published
    03 Jun 2016
    Read more

  • Switching insurer in the Irish voluntary health insurance market: determinants, incentives, and risk equalization

    Published
    10 Sep 2015
    Read more

  • Response to McKinnell et al's original article "cost-benefit analysis from the hospital perspective of universal active screening followed by contact precautions for methicillin-resistant Staphylococcus aureus carriers

    Published
    17 Jun 2015
    Read more

  • Cost-effectiveness of a national public access defibrillation programme

    Published
    16 Mar 2015
    Read more

  • Endpoints for relative effectiveness assessment (REA) of pharmaceuticals

    Published
    06 Mar 2015
    Read more
Title Published View
Economic Evaluation of Selective Neonatal Bacillus Calmette-Guérin Vaccination of High-risk Infants in Ireland
Contribution of stakeholder engagement to the impact of a health technology assessment: an Irish case study
Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiolog
Clinical-effectiveness of self-management interventions in chronic obstructive pulmonary disease: An overview of reviews
The HIQA's Health Technology Assessment of Breast Screening: Highlighting Some of the Challenges Posed by Evaluations of Screening Programs
Economic evaluation of chronic disease self-management for people with diabetes: a systematic reviewv
Cost-Effectiveness of a National Opportunistic Screening Program for Atrial Fibrillation in Ireland
Systematic screening for the detection of atrial fibrillation: Update
Switching insurer in the Irish voluntary health insurance market: determinants, incentives, and risk equalization
Response to McKinnell et al's original article "cost-benefit analysis from the hospital perspective of universal active screening followed by contact precautions for methicillin-resistant Staphylococcus aureus carriers
Cost-effectiveness of a national public access defibrillation programme
Endpoints for relative effectiveness assessment (REA) of pharmaceuticals